Cardiovascular comorbidity and its risk factors in rheumatoid arthritis;Kardiovaskuläre Komorbidität und ihre Risikofaktoren bei rheumatoider Arthritis

Zeitschrift fur Rheumatologie

Volumn 70, Issue 6, 2011, Pages 464-472

  Kleinert, S ^a   Krueger, K ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Praxiszentrum St Bonifatius   (Germany)

Author keywords

Arthritis; Cardiovascular risk; EULAR recommendations; Inflammation; Mortality; Rheumatoid

Indexed keywords

GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; HUMAN; INFLAMMATION; RHEUMATOID ARTHRITIS; RISK REDUCTION;

AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MIDDLE AGED; PEPTIDES, CYCLIC; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RHEUMATOID FACTOR; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054875803     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-011-0755-0     Document Type: Article

References (30)

1. Banerjee S, Compton AP, Hooker RS et al (2008) Cardiovascular outcomes in male veterans with rheumatoid arthritis. Am J Cardiol 101:1201-1205
2. Böhm M, Laufs U, Hamm C et al (2007) Position paper on statin therapy. Clin Res Cardiol (Suppl 2):8-15
3. Boyer JF, Gourraud PA, Cantagrel A et al (2011) Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 78:179-183
4. Davis JM 3rd, Maradit Kremers H, Crowson CS et al (2007) Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56:820-830 (Pubitemid 46399429)
5. Deutsche Hochdruckliga e.V. DHL®, Deutsche Hypertonie Gesellschaft (2008) Leitlinien zur Behandlung der arteriellen Hypertonie. AWMF-Leitlinien-Register-Nr. 046/001 (Stand Juni 2008)
6. Deutsche Hochdruckliga e.V. DHL®, Deutsche Hypertonie Gesellschaft (2010) Zielblutdruckwerte bei Patienten mit Diabetes mellitus. Stellungnahme vom 07. September 2010
7. Dixon WG, Watson KD, Lunt M et al (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905-2912 (Pubitemid 47502736)
8. Edwards CJ, Syddall H, Goswami R et al (2007) The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 93:1263-1267 (Pubitemid 47492917)
9. Gohlke H, Von Schacky C (2005) Total risk for cardiovascular disease. At what point is medical prophylactic medication useful? Z Kardiol 94(Suppl 3):III/6-10
10. Goodson NJ, Brookhart AM, Symmons DP et al (2009) Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis 68:367-372
11. Greenberg JD, Kremer JM, Curtis JR et al (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 70:576-582
12. Holmqvist ME, Wedren S, Jacobsson LT et al (2010) Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 268:578-585
13. Keil U, Fitzgerald AP, Gohlke H et al (2005) Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen. Die neuen SCORE-Deutschland-Tabellen für die Primärprävention. Dtsch Arztebl 102:A1808-A1812
14. Kitas GD, Gabriel SE (2011) Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 70:8-14
15. Kramer HR, Giles JT (2011) Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity. Arthritis Care Res (Hoboken) 63:484-499
16. Liang KP, Kremers HM, Crowson CS et al (2009) Autoantibodies and the risk of cardiovascular events. J Rheumatol 36:2462-2469
17. Listing J, Strangfeld A, Kekow J et al (2008) Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58:667-677 (Pubitemid 351364864)
18. Lopez-Longo FJ, Oliver-Minarro D, De La Torre I et al (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61:419-424
19. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462-1536
20. Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121-2158
21. Maradit-Kremers H, Nicola PJ, Crowson CS et al (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722-732 (Pubitemid 40365093)
22. Matthaei S, Bierwirth R, Fritsche A et al (2010) Behandlung des Diabetes mellitus Typ 2. Diabetes Metab 5(Suppl 2):127-132
23. Myasoedova E, Crowson CS, Kremers HM et al (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:482-487
24. Naranjo A, Sokka T, Descalzo MA et al (2008) Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10:R30
25. Peters MJL, Symmons DPM, Mccarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325-331
26. Solomon DH, Kremer J, Curtis JR et al (2010) Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 69:1920-1925
27. Taylor F, Ward K, Moore TH et al (2011) Statins for the primary prevention of cardiovascular disease. Cochrane database Syst Rev:CD004816
28. Van Halm VP, Peters MJ, Voskuyl AE et al (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68:1395-1400
29. Westlake SL, Colebatch AN, Baird J et al (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49:295-307
30. Wolfe F, Michaud K (2008) The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 58:2612-2621